Skip to main content

Table 2 Pathogenicity evaluation based on the POLE-score system

From: A novel somatic mutation in POLE exonuclease domain associated with ultra-mutational signature and MMR deficiency in endometrial cancer: a case report

Mutation analysis

Results

POLE-score

C > A over 20%

27.5% (76)

1

T > G over 4%

3.99% (11)

0

Indels below 5%

0.36% (1)

1

 C > G below 0.6%

0.36% (1)

1

TMB over 100 muts/Mb

203.8

1

Recurrent variant in EC

no

0

Total POLE-score

4